Lunai Bioworks achieves complete regression of both primary and metastatic pancreatic tumors in preclinical humanized models, marking a breakthrough i…

Lunai Bioworks (NASDAQ: LNAI), an AI-powered drug discovery and biodefense company, has announced a major scientific ...
TipRanks on MSN

Lunai Bioworks announces regression of tumors with immune cell therapy

Lunai Bioworks (LNAI) has announced a major scientific breakthrough: its next-generation immune cell therapy led to complete regression of both ...